Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Lymphopenia and neutropenia are associated with subsequent incident proteinuria in Danish patients with systemic lupus erythematosus.

Tanha N, Hansen RB, Yang J, Lange T, Nielsen CT, Helleberg M, Kamper AL, Faurschou M, Jacobsen S.

Scand J Rheumatol. 2019 Oct 15:1-9. doi: 10.1080/03009742.2019.1650107. [Epub ahead of print]

PMID:
31612777
2.

Atherosclerosis and renal disease involvement in patients with systemic lupus erythematosus: a cross-sectional cohort study.

Hermansen ML, Sandholt B, Fuchs A, Sillesen H, Køber L, Kofoed KF, Faurschou M, Jacobsen S.

Rheumatology (Oxford). 2018 Nov 1;57(11):1964-1971. doi: 10.1093/rheumatology/key201.

PMID:
30016488
3.

Plasma levels of β2-microglobulin are associated with atherosclerosis in patients with systemic lupus erythematosus: a cross-sectional cohort study.

Leffers HCB, Hermansen ML, Sandholt B, Fuchs A, Sillesen H, Køber L, Kofoed KF, Faurschou M, Jacobsen S.

Lupus. 2018 Aug;27(9):1517-1523. doi: 10.1177/0961203318784661. Epub 2018 Jun 28.

PMID:
29954284
4.

Long-term risk and outcome of infection-related hospitalization in granulomatosis with polyangiitis: a nationwide population-based cohort study.

Faurschou M, Obel N, Baslund B.

Scand J Rheumatol. 2018 Nov;47(6):475-480. doi: 10.1080/03009742.2018.1461924. Epub 2018 May 9.

PMID:
29741122
5.

Clinical and Serological Associations with the Development of Incident Proteinuria in Danish Patients with Systemic Lupus Erythematosus.

Tanha N, Hansen RB, Nielsen CT, Faurschou M, Jacobsen S.

J Rheumatol. 2018 Jul;45(7):934-941. doi: 10.3899/jrheum.170933. Epub 2018 Apr 15.

PMID:
29657143
6.

The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.

Hermansen ML, Lindhardsen J, Torp-Pedersen C, Faurschou M, Jacobsen S.

Rheumatology (Oxford). 2017 May 1;56(5):709-715. doi: 10.1093/rheumatology/kew475.

PMID:
28053276
7.

Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus.

Tanha N, Pilely K, Faurschou M, Garred P, Jacobsen S.

Clin Rheumatol. 2017 Feb;36(2):335-341. doi: 10.1007/s10067-016-3508-2. Epub 2016 Dec 15.

PMID:
27981461
8.

Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.

Faurschou M, Ahlström MG, Lindhardsen J, Obel N, Baslund B.

J Rheumatol. 2017 Jan;44(1):78-83. doi: 10.3899/jrheum.160797. Epub 2016 Oct 15.

PMID:
27744394
9.

Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study.

Hermansen ML, Lindhardsen J, Torp-Pedersen C, Faurschou M, Jacobsen S.

J Rheumatol. 2016 Jul;43(7):1335-9. doi: 10.3899/jrheum.151221. Epub 2016 May 1.

PMID:
27134247
10.

Impact of pre-existing co-morbidities on mortality in granulomatosis with polyangiitis: a cohort study.

Faurschou M, Ahlström MG, Lindhardsen J, Baslund B, Obel N.

Rheumatology (Oxford). 2016 Apr;55(4):649-53. doi: 10.1093/rheumatology/kev390. Epub 2015 Nov 28.

PMID:
26615030
11.

Pronounced Risk of Fractures among Elderly Men Affected by Granulomatosis with Polyangiitis.

Faurschou M, Baslund B, Obel N.

J Rheumatol. 2015 Sep;42(9):1667-71. doi: 10.3899/jrheum.141566. Epub 2015 Aug 1.

PMID:
26233512
12.

Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Trials.

Graudal N, Hubeck-Graudal T, Faurschou M, Baslund B, Jürgens G.

Arthritis Care Res (Hoboken). 2015 Nov;67(11):1487-95. doi: 10.1002/acr.22618.

13.

Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.

Faurschou M, Mellemkjaer L, Voss A, Keller KK, Hansen IT, Baslund B.

Rheumatology (Oxford). 2015 Aug;54(8):1345-50. doi: 10.1093/rheumatology/keu372. Epub 2014 Sep 17.

PMID:
25234661
14.

Mortality in patients with giant cell arteritis.

Baslund B, Helleberg M, Faurschou M, Obel N.

Rheumatology (Oxford). 2015 Jan;54(1):139-43. doi: 10.1093/rheumatology/keu303. Epub 2014 Aug 13.

PMID:
25122725
15.

High risk of pulmonary embolism and deep venous thrombosis but not of stroke in granulomatosis with polyangiitis (Wegener's).

Faurschou M, Obel N, Baslund B.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1910-4. doi: 10.1002/acr.22423.

16.

Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis.

Walsh M, Faurschou M, Berden A, Flossmann O, Bajema I, Hoglund P, Smith R, Szpirt W, Westman K, Pusey CD, Jayne DR; European Vasculitis Study Group.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1571-6. doi: 10.2215/CJN.00100114. Epub 2014 Jun 26.

17.

MBL2 gene variants coding for mannose-binding lectin deficiency are associated with increased risk of nephritis in Danish patients with systemic lupus erythematosus.

Tanha N, Troelsen L, From Hermansen ML, Kjær L, Faurschou M, Garred P, Jacobsen S.

Lupus. 2014 Oct;23(11):1105-11. doi: 10.1177/0961203314536478. Epub 2014 May 21.

PMID:
24850777
18.

Anti-B cell antibody therapies for inflammatory rheumatic diseases.

Faurschou M, Jayne DR.

Annu Rev Med. 2014;65:263-78. doi: 10.1146/annurev-med-070912-133235. Epub 2013 Oct 18. Review.

PMID:
24160940
19.
20.

ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships.

Mahr A, Heijl C, Le Guenno G, Faurschou M.

Best Pract Res Clin Rheumatol. 2013 Feb;27(1):45-56. doi: 10.1016/j.berh.2012.12.003. Review.

PMID:
23507056
21.

Reply: To PMID 22614882.

Faurschou M, Westman K, Rasmussen N, de Groot K, Flossmann O, Höglund P, Jayne D.

Arthritis Rheum. 2013 Mar;65(3):844. doi: 10.1002/art.37794. No abstract available.

22.

Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

Faurschou M, Westman K, Rasmussen N, de Groot K, Flossmann O, Höglund P, Jayne DR; European Vasculitis Study Group.

Arthritis Rheum. 2012 Oct;64(10):3472-7. doi: 10.1002/art.34547.

23.

Treatment of orbital inflammation with rituximab in Wegener's granulomatosis.

Baslund B, Wiencke AK, Rasmussen N, Faurschou M, Toft PB.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S7-10. Epub 2012 May 10.

PMID:
22272561
24.

High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.

Dreyer L, Faurschou M, Mogensen M, Jacobsen S.

Arthritis Rheum. 2011 Oct;63(10):3032-7. doi: 10.1002/art.30483.

25.

High risk of ischemic heart disease in patients with lupus nephritis.

Faurschou M, Mellemkjaer L, Starklint H, Kamper AL, Tarp U, Voss A, Jacobsen S.

J Rheumatol. 2011 Nov;38(11):2400-5. doi: 10.3899/jrheum.110329. Epub 2011 Sep 1.

PMID:
21885497
26.

A population-based study of Takayasu´s arteritis in eastern Denmark.

Dreyer L, Faurschou M, Baslund B.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S40-2. Epub 2011 May 11.

PMID:
21385546
27.

Evidence-based recommendations for treatment with methotrexate in rheumatic disorders.

Madsen OR, Faurschou M, Loft AG, Sørensen IJ, Knudsen JB, Baslund B, Hansen A, Hansen MS, Østergaard M.

Dan Med Bull. 2010 Oct;57(10):A4190.

PMID:
21040680
28.

Impaired health-related quality of life in patients treated for Wegener's granulomatosis.

Faurschou M, Sigaard L, Bjorner JB, Baslund B.

J Rheumatol. 2010 Oct;37(10):2081-5. doi: 10.3899/jrheum.100167. Epub 2010 Aug 3.

PMID:
20682665
29.

Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis.

Faurschou M, Dreyer L, Kamper AL, Starklint H, Jacobsen S.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):873-80. doi: 10.1002/acr.20116.

30.

Renal cell apoptosis in human lupus nephritis: a histological study.

Faurschou M, Penkowa M, Andersen CB, Starklint H, Jacobsen S.

Lupus. 2009 Oct;18(11):994-9. doi: 10.1177/0961203309106175.

PMID:
19762401
31.

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.

Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, Baslund B.

Arthritis Rheum. 2009 Apr;60(4):1187-92. doi: 10.1002/art.24386.

32.

Cancer preceding Wegener's granulomatosis: a case-control study.

Faurschou M, Mellemkjaer L, Sorensen IJ, Thomsen BS, Dreyer L, Baslund B.

Rheumatology (Oxford). 2009 Apr;48(4):421-4. doi: 10.1093/rheumatology/kep009. Epub 2009 Feb 12.

PMID:
19213850
33.

Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.

Baek Sørensen R, Faurschou M, Troelsen L, Schrama D, Jacobsen S, Becker JC, Thor Straten P, Andersen MH.

J Invest Dermatol. 2009 Aug;129(8):1992-9. doi: 10.1038/jid.2009.10. Epub 2009 Feb 12.

34.

The renal metallothionein expression profile is altered in human lupus nephritis.

Faurschou M, Penkowa M, Andersen CB, Starklint H, Jacobsen S.

Arthritis Res Ther. 2008;10(4):R76. doi: 10.1186/ar2450. Epub 2008 Jul 6.

35.

Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.

Faurschou M, Sorensen IJ, Mellemkjaer L, Loft AG, Thomsen BS, Tvede N, Baslund B.

J Rheumatol. 2008 Jan;35(1):100-5. Epub 2007 Oct 15.

PMID:
17937462
36.

Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.

Faurschou M, Starklint H, Halberg P, Jacobsen S.

J Rheumatol. 2006 Aug;33(8):1563-9.

PMID:
16881113
37.

Prodefensins are matrix proteins of specific granules in human neutrophils.

Faurschou M, Kamp S, Cowland JB, Udby L, Johnsen AH, Calafat J, Winther H, Borregaard N.

J Leukoc Biol. 2005 Sep;78(3):785-93. Epub 2005 Jun 8.

PMID:
15944211
38.

[Wasted research continuity and lost hours!].

Faurschou M, Josefsson P, Masmas T, Petersen SL, Salomo M, Udby L.

Ugeskr Laeger. 2004 Feb 2;166(6):507-8. Danish. No abstract available.

PMID:
15045726
39.

Neutrophil granules and secretory vesicles in inflammation.

Faurschou M, Borregaard N.

Microbes Infect. 2003 Nov;5(14):1317-27. Review.

PMID:
14613775
40.

Defensin-rich granules of human neutrophils: characterization of secretory properties.

Faurschou M, Sørensen OE, Johnsen AH, Askaa J, Borregaard N.

Biochim Biophys Acta. 2002 Aug 19;1591(1-3):29-35.

41.
42.
43.
44.

[Virus-associated hemophagocytic syndrome. Diagnosis and treatment].

Faurschou M, Nielsen OJ, Hansen PB, Hasselbalch HC.

Ugeskr Laeger. 1998 Oct 19;160(43):6198-200. Review. Danish.

PMID:
9803867
45.

[The bronchodilating effect of ephedrine tablets in bronchial asthma].

Faurschou M, Svendsen UG.

Ugeskr Laeger. 1993 Nov 15;155(46):3784-5. Danish. No abstract available.

PMID:
8256378

Supplemental Content

Loading ...
Support Center